Colistin Dosing for Severe Infections with Normal Renal Function
For patients with normal renal function and severe infections such as ventilator-associated pneumonia or sepsis, administer a loading dose of 9 million IU of colistin followed by a maintenance dose of 9 million IU/day divided into 2-3 doses (equivalent to 4.5 million IU every 12 hours). 1, 2, 3
Loading Dose: Critical First Step
The loading dose is non-negotiable and must be given to all patients regardless of renal function 1, 2, 3:
- Administer 6-9 million IU as a loading dose (9 million IU is preferred for severe infections) 1, 2, 3
- This is equivalent to approximately 5 mg/kg based on ideal body weight 3, 4
- The loading dose is essential because colistin has a relatively long half-life, and without it, therapeutic plasma concentrations are not achieved for 2-3 days, leading to suboptimal treatment during the critical early infection period 1, 2
- Studies in critically ill patients with VAP showed colistin was undetectable in bronchoalveolar lavage at 2 hours after standard dosing without a loading dose 1
Maintenance Dosing
After the loading dose, continue with maintenance therapy 1, 2, 3, 4:
- 9 million IU/day divided into 2-3 doses (most commonly 4.5 million IU every 12 hours) 1, 2, 3
- Alternative weight-based dosing: 2.5-5 mg/kg/day divided into 2-4 doses for patients with normal renal function 3, 4
- For obese patients, calculate dosing based on ideal body weight, not actual body weight 4
Administration Method
Administer as a 4-hour infusion to optimize pharmacokinetic/pharmacodynamic properties 1, 3:
- This extended infusion may allow treatment of infections involving strains with MIC up to 8 mg/L 1
- The FDA label also describes direct intermittent administration over 3-5 minutes or continuous infusion options, but the 4-hour infusion is preferred based on PK/PD optimization 1, 4
Critical Dosing Conversions
Understanding colistin dosing units is essential to avoid medication errors 1, 2, 3:
- 1 million IU of colistin = 80 mg of colistimethate sodium (CMS) 1, 2, 3
- Colistin is administered as the inactive prodrug CMS, which converts to active colistin in vivo 1, 2, 3
- The 150 mg vial should be reconstituted with 2 mL Sterile Water for Injection to provide 75 mg/mL colistin base activity 4
Monitoring Requirements
Close monitoring of renal function is mandatory 2, 3:
- Check renal function at baseline and 2-3 times per week during treatment 2
- Acute kidney injury during colistin treatment is a major factor related to clinical failure and mortality 2, 5, 3
- Nephrotoxicity is dose-dependent but usually reversible within one week after discontinuation 5
- Research shows nephrotoxicity rates of 27-39% with colistin, with higher rates in patients with advanced age or high SOFA scores 6
Common Pitfalls to Avoid
Failure to give a loading dose is the most critical error 1, 2, 7:
- Approximately one-third to half of patients in clinical practice do not receive a loading dose 7
- Studies demonstrate that patients receiving a loading dose have significantly better clinical outcomes (55.2% vs 35.8% favorable outcomes at day 14) and microbiological eradication rates (50% vs 27.3%) compared to those without 7
- The loading dose does not significantly increase nephrotoxicity risk in patients with normal renal function 7
Inadequate dosing for pathogens with higher MICs 8:
- Standard dosing achieves >90% probability of target attainment only for MIC ≤0.5 μg/mL 8
- For MIC ≥1 μg/mL, standard dosing poses a risk of subtherapeutic exposure 8
- Consider combination therapy for organisms with MIC ≥1 mg/L, as colistin monotherapy may be insufficient 9
Alternative: Polymyxin B
Consider polymyxin B as an alternative, particularly in patients at high risk for renal dysfunction 5:
- Polymyxin B has significantly lower nephrotoxicity (11.8% vs 39.3% with colistin) 5
- Loading dose: 2-2.5 mg/kg; maintenance: 1.5-3 mg/kg/day in 2 doses 1, 5
- Unlike colistin, polymyxin B is administered as the active drug and plasma concentrations are not influenced by renal function 1, 5
- No dose adjustment needed for continuous renal replacement therapy 1, 5